Global economic fluctuations and shifting trade policies are casting a long shadow over the pharmaceutical supply chain. Companies are increasingly "friend-shoring" or "near-shoring" their outsourced services to mitigate the risks of geopolitical instability and logistics disruptions. This has led to a resurgence in service hubs within North America and Europe, even as Asia-Pacific remains a...